Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-23

FDA Approved: DOXAZOSIN — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for doxazosin (doxazosin mesylate) from Mylan Pharmaceuticals. The drug is traditionally used to treat hypertension and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DOXAZOSIN MESYLATE (DOXAZOSIN MESYLATE)
  • Doxazosin (doxazosin)

Snippet

SUPPL AP for DOXAZOSIN (DOXAZOSIN)